Average Co-Inventor Count = 5.01
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Sunovion Pharmaceuticals Inc. (14 from 130 patents)
2. University of Delaware (1 from 430 patents)
15 patents:
1. 10604536 - Substituted cyclopropanes as PDE-10 inhibitors
2. 10562878 - Cycloalkylamines as monoamine reuptake inhibitors
3. 10428021 - Triple reuptake inhibitors and methods of their use
4. 9994590 - Substituted [1,2,4]triazolo[1,5-a]pyrazines as phosphodiesterase inhibitors
5. 9868718 - Cycloalkylamines as monoamine reuptake inhibitors
6. 9850204 - Triple reuptake inhibitors and methods of their use
7. 9586888 - Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
8. 9580409 - Modulators of opioid receptors and methods of use thereof
9. 9505751 - Substituted [1,2,4]triazolo[1,5-a]pyrazines as phosphodiesterase inhibitors
10. 9133117 - Triple reuptake inhibitors and methods of their use
11. 8877975 - Cycloalkylamines as monoamine reuptake inhibitors
12. 8669291 - Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
13. 8592608 - Triple reuptake inhibitors and methods of their use
14. 8053603 - Tetralone-based monoamine reuptake inhibitors
15. 7345035 - Treatment of osteoporosis and autoimmune disease with astrogorgiadiol